Janet Fairley is a Dermatology physician affiliated with University of Iowa. OpenAlex indexes 166 publications with 8,788 citations (h-index 48); ClinicalTrials.gov lists 2 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Dermatology profiles in the FindMyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- Efficacy and Safety of Omalizumab in Bullous Pemphigoid
Sponsor: University of Iowa
- Use of Infliximab for the Treatment of Pemphigus Vulgaris
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- RegeneronProgram year20256 paymentsResearch$12,170
- Regeneron Pharmaceuticals, Inc.Program year20251 payment$30
- AstraZenecaProgram year20241 paymentResearch$8,398
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
NIH funding
2 NIH research awards on record, funded 2011–2021 per NIH RePORTER. The latest:
- Modulation of Cutaneous Autoimmunity by Staphylococcus Aureus
University of Iowa
FY2021$198,720R21AG065980 - Modulation of Cutaneous Autoimmunity by Staphylococcus Aureus
University of Iowa
FY2020$240,070R21AG065980
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Expert recommendations for the management of autoimmune bullous diseases during the COVID‐19 pandemic
Journal of the European Academy of Dermatology and Venereology
2020 - The Intersection of IgE Autoantibodies and Eosinophilia in the Pathogenesis of Bullous Pemphigoid
Frontiers in Immunology
2019 - International Bullous Diseases Group: consensus on diagnostic criteria for epidermolysis bullosa acquisita
British Journal of Dermatology
2017 - Eosinophils Mediate Tissue Injury in the Autoimmune Skin Disease Bullous Pemphigoid
Journal of Investigative Dermatology
2017
Similar KOLs
Other experts from the same institution or the same specialty.
Lawrence Hunsicker, MD
University of Iowa
Brian Olshansky, MD
University of Iowa
Robert Weiss, MD
University of Iowa
Carla Nester, MD
University of Iowa
Bridget Grant, MD
Bassett Medical Center
Robert Modlin, MD
University of California, Los Angeles
Andrew Blauvelt, MD
University of Maryland School of Medicine
Howard Maibach, MD
University of California, San Francisco
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”